VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1037943
Sex: F
Age:
State: PA

Vax Date: 02/02/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: pulse; Result Unstructured Data: Test Result:nomrally 70; Test Name: pulse; Result Unstructured Data: Test Result:99-104

Allergies:

Symptoms: Initial soreness in shoulder; unusually high pulse rate; feeling of tired; achy; cold; This is a spontaneous report from a contactable consumer. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration second dose on 02Feb2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose for Covid-19 Immunization on an unspecified date and patient age was 42-year-old. On an unspecified date, the patient experienced initial soreness in shoulders. Next day unusually high pulse rate (99-104); pulse was normally 70. Also, the patient experienced feeling of tired, achy, and cold. No fever. The patient did not received treatment for the events. The outcome of the events was not recovered. The reporter assess the events as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037944
Sex: F
Age:
State: NC

Vax Date: 01/29/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient herself). A 75-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 29Jan2021 (at 14:30) at single dose on the left arm for COVID-19 immunisation, administered at clinic. Relevant medical history included persistent genital arousal disorder. Past drug history included allergy to codeine. The subject was receiving concomitant medications (unspecified). No other vaccine was received in four weeks. On 01Feb2021, the patient developed severe fatigue, inflammation, swelling, and soreness under tongue....5 days and counting (as reported). The events were assessed as non-serious. The patient had not recovered from the events. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1037945
Sex: F
Age:
State: TX

Vax Date: 01/28/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (reporting for herself). A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration (left arm) on 28Jan2021 18:30 (at the age of 35 years) at single dose for Covid-19 immunization. The patient's medical history was not reported. The patient has no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), clonazepam, and "omniprozol" (as reported); all taken from an unspecified date (reported as received within 2 weeks of vaccination) for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021 18:30 (also reported as "24 hours after vaccine"), the patient experienced pain and swelling at injection site. The patient also experienced rash on leg and elbows starting day 3 (as reported) to present. There was no treatment received for the adverse events. The outcome of events was not recovered. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious. Information on the lot/batch number has been requested.

Other Meds: ZOLOFT; CLONAZEPAM

Current Illness:

ID: 1037946
Sex: F
Age:
State: NV

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: Labs; Result Unstructured Data: Test Result:Negative for autoimmune disease

Allergies:

Symptoms: First dose administration on 19Dec2020 and second dose administration on 12Jan2021; Dyspnea; Rash; Urticaria and folliculitis with near resolution. Severe exacerbation after both vaccinations 2 and 1; Urticaria and folliculitis with near resolution. Severe exacerbation after both vaccinations 2 and 1; Urticaria and folliculitis with near resolution. Severe exacerbation after both vaccinations 2 and 1; This is a spontaneous report from a contactable healthcare professional (the patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El1283, expiration date not reported), via an unspecified route of administration (left arm) on 12Jan2021 at a single dose, for COVID-19 immunization. Medical history was not reported. Concomitant medication included cefalexin monohydrate (KEFLEX), cefdinir, fexofenadine hydrochloride (ALLEGRA), cetirizine hydrochloride (ZYRTEC ALLERGY), and triamcinolone. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5760, on right arm, on 19Dec2020, and experienced urticaria and folliculitis with severe exacerbation after both vaccination. It was reported that on Jan2021, the patient was under successful treatment for urticaria and folliculitis with near resolution. Severe exacerbation after both vaccinations 2 and 1; experience of rash and dyspnea on Jan2021 required steroids and epipen. Treatment included Prednisone course, epipen, and H2 blockers. The adverse event resulted in a doctor or healthcare professional office/clinic visit. The patient's labs on an unknown date was negative for autoimmune disease. It was also reported that the patient had first dose administration on 19Dec2020 and second dose administration on 12Jan2021. The patient was recovering from all events, except for "First dose administration on 19Dec2020 and second dose administration on 12Jan2021" with outcome of unknown.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds: KEFLEX [CEFALEXIN MONOHYDRATE]; CEFDINIR; ALLEGRA; ZYRTEC ALLERGY; TRIAMCINOLONE

Current Illness:

ID: 1037947
Sex: F
Age:
State: NY

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: trouble lifting my arm; Pain in arm; Nauseous; Chills; Urge to cry; This is a spontaneous report from a contactable consumer who reported for herself . This 41-years-old no pregnant female patient received first dose of bnt162b2 (BNT162B2) from LOT# E19262, on 03Feb2021 17:30 on right arm at SINGLE DOSE for covid-19 immunisation .Age at vaccination:41 years. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine . The patient received other medications within 2 weeks of vaccination .Medical history included :Allergy to adhesive, ADHD, high blood pressure (HBP), depression, anxiety, gerd. On 04Feb2021 20:00 the patient experienced chills, urge to cry, trouble lifting in arm , pain in arm and she was Nauseous. Events reported as non serious .No treatment received. Outcome was not recovered. Prior to vaccination the patient was not diagnosed with COVID-19Since the vaccination, the patient has not been tested for COVID-19

Other Meds:

Current Illness:

ID: 1037948
Sex: F
Age:
State: MI

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:102

Allergies:

Symptoms: This is a spontaneous report from a contactable other hcp reported for herself. A 49-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9265), intramuscular on the right arm at the age of 49 years old, on 02Feb2021 at a SINGLE DOSE for covid-19 immunisation. Medical history reported as none. The patient had the first dose of the vaccine on 13Jan2021. The patient experienced fever 102, body aches, could barley move on 03Feb2021 12:00. The patient underwent lab tests and procedures which included body temperature: 102 on an unspecified date. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 1037949
Sex: F
Age:
State: CA

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable unspecified healthcare professional (patient). A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: 1284, via an unspecified route of administration in the right arm on 16Jan2021 15:00 at SINGLE DOSE for covid-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included sulfur allergy. Patient was taking unspecified blood pressure medication/s concomitantly. Patient previously took codeine and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 17Jan2021 08:00, the patient experienced just redness and swelling at injection site, no other side effects. Patient did not receive treatment for the events. The outcome of events was recovered. the events were considered as non-serious. Follow-up attempts are completed. No further information is expected. Information on the batch/lot number has been obtained.

Other Meds:

Current Illness:

ID: 1037950
Sex: F
Age:
State: NC

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210202; Test Name: temp; Result Unstructured Data: Test Result:100.6; Test Date: 202102; Test Name: temp; Result Unstructured Data: Test Result:around 99.8; Comments: temp lower but still around 99.8 (normal for me 97.2)

Allergies:

Symptoms: This is a spontaneous report from a contactable nurse reported for herself. A 60-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot EL3247) intramuscular in right arm on 01Feb2021 at 11:30 am (at 60 years) at single dose for covid-19 immunisation . Medical history included hypertension (HTN) , hypergammaglobulinaemia benign monoclonal (MGUS) , mononucleosis (recent mononucleosis one year before). Patient was not pregnant. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), hydrochlorothiazide/ losartan potassium (HYZAAR), amfepramone hydrochloride (TENUATE). The patient previously took IV dramamine, tetanus and ceclor and experienced allergy. Previously, on 18Jan2021 at 10:30 am (at 60 years) she took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot EL3248) intramuscular in right arm for covid-19 immunisation. Patient took the 1st dose of the vaccine on 18Jan2021 and 2nd dose on 01Feb2021 (inappropriate schedule of vaccine administered). Events were described as follows: next day, on 02Feb2021 at 06:00 temperature of 100.6, arthralgias and myalgias, dizziness. Second day (Feb2021), temp lower but still around 99.8 (normal for her 97.2), vasovagal, dizziness, arthralgias and myalgias. Events were non serious. Patient (a nurse) treated herself with dramamine for the dizziness, Nyquil and Advil. The final outcome of pyrexia, vasovagal, dizziness, arthralgias and myalgias was recovering.

Other Meds: EFFEXOR; HYZAAR; TENUATE

Current Illness:

ID: 1037951
Sex: M
Age:
State: MI

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness; headache; fatigue; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3248, expiry date unknown), via an unspecified route of administration on 02Feb2021 at 06:15 AM at a single dose on the left arm in the workplace clinic for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. The patient received the first dose of BNT162B2 (lot number: EL3248) on 13Jan2021 at 07:15 AM on the left arm for COVID-19 immunization. The patient experienced soreness, headache and fatigue on 03Feb2021 at 10:00 AM. The patient did not receive treatment for the events. The outcome of the events was unknown. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1037952
Sex: F
Age:
State: OH

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored program. A 78-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 25Jan2021 at 13:00 (at 78 years) at single dose for COVID-19 immunization. The patient medical history included anxiety, headache, dry eye and low potassium, each from an unknown date and unknown if ongoing. The patient's concomitant medication included potassium oral at 10 meq daily for low potassium, cholecalciferol (D3) oral at 2000 iU once a day to help with bones, fish oil oral at 1200 mg once a day, alprazolam at 0.5 mg as needed (take one three times a day) for anxiety, clonazepam oral at 0.5 mg once a day for anxiety, nortriptyline HCl oral at 10 mg once a day, paracetamol (TYLENOL) at 500 mg as needed for headache, estradiol (SYSTEN) ophthalmic one drop as needed, all from an unknown date and ongoing. The patient experienced one or two hours after the vaccine (on 25Jan2021), she went to talk, she couldn't get her sentence straight. She knew what she wanted to say but she couldn't say it. Her first thought was that she was having a stroke and it really scared her. She became very tired and went to sleep, when she woke up, she was talking straight but she was still really tired. The next morning (on 26Jan2021) she had diarrhea three time and after that she felt better. The patient outcome of speech disorder and diarrhea was recovered on 26Jan2021 and the outcome of tiredness was recovering. The information on the batch number has been requested.

Other Meds: POTASSIUM; D3; FISH OIL; ALPRAZOLAM; CLONAZEPAM; NORTRIPTYLINE HCL; TYLENOL; SYSTEN [ESTRADIOL]

Current Illness:

ID: 1037953
Sex: F
Age:
State: OH

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER BIONTECH COVID-19 VACCINE; unknown lot number and expiration date), via an unspecified route of administration right arm on 03Feb2021 10:30 at a single dose for covid-19 immunization. The patient medical history was none. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included vitamin d [vitamin d nos] (VITAMIN D), probiotics, chondroitin sulfate, glucosamine (GLUCOSAMINE CHONDROITIN), thyroid (ARMOUR THYROID), magnesium glycinate, progesterone and melatonin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine in her workplace clinic. On 04Feb2021 04:30 AM, the patient reported that she woke the morning after the vaccine, and she was unable to walk without assistance due to dizziness. The adverse event result in a doctor or other healthcare professional office/clinic visit. It was unknown if the patient received treatment for the adverse events. The events were considered non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was not recovered. The following information on the batch/lot number has been requested.

Other Meds: VITAMIN D [VITAMIN D NOS]; PROBIOTICS; GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE]; ARMOUR THYROID; MAGNESIUM GLYCINATE; PROGESTERONE; MELATONIN

Current Illness:

ID: 1037954
Sex: F
Age:
State: FL

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Extremely sore injection site; woke me from sleep; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 03Feb2021 18:00 at a SINGLE DOSE for covid-19 immunisation. Medical history was reported as none. The patient experienced extremely sore injection site and woke me from sleep on an unspecified date. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037955
Sex: F
Age:
State: NY

Vax Date: 01/31/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: trouble sleeping; lump in her throat; high blood pressures; feeling very shaky and very weak; feeling very shaky and very weak; feeling unwell; alternating slow heartbeat and fast heartbeat; a weird feeling in her head like pressure but not a headache/pressure feeling in my head; they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction.; This is a spontaneous report from a contactable consumer. A 65 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 31Jan2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included allergic to shrimp, lupus anticoagulant syndrome, chronic kidney disease and antiphospholipid syndrome. Concomitant medications included amlodipine, HCTZ, losartan, acetylsalicylic acid (ASPIRIN (E.C.) and atorvastatin calcium (LIPITOR ORIFARM). The patient informed that immediately after receiving the injection she felt a lump in her throat and could not swallow, still present now. Patient also informed that after vaccination she was having a very high blood pressures, feeling very shaky and very weak, a weird feeling in her head like pressure but not a headache, trouble sleeping because of the pressure feeling in my head, feeling unwell and alternating slow heartbeat and fast heartbeat. Patient also reported she had scheduled an allergist appointment and they are going to check me for all the ingredients in the Pfizer vaccine that could give me an allergic reaction. At the time of the reporting event outcome was unknown.

Other Meds: AMLODIPINE; HCTZ; LOSARTAN; ASPIRIN (E.C.); LIPITOR ORIFARM

Current Illness:

ID: 1037956
Sex: F
Age:
State: TX

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable other healthcare professional (patient). A 77-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EN5318) via an unspecified route of administration on the left arm on 31Jan2021 10:00 at a single dose for COVID-19 immunization. Medical history included diabetes (reported as diabetis), high blood pressure, allergy to penicillin and sulfer; and COVID-19 (prior to vaccination). Concomitant medications included metformin, apixaban (ELIQUIS), valsartan, propafenone and amlodipine besilate (AMLODI). On 31Jan2021 10:30 AM, the patient experienced redness, warm and itchy around injection site. No treatment was received for the events. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was not recovered.

Other Meds: METFORMIN; ELIQUIS; VALSARTAN; PROPAFENONE; AMLODI

Current Illness:

ID: 1037957
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient (age at vaccination 35-years-old) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date. At the time of the report, the patient recovered from the event on an unspecified date. No treatment was received for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior vaccination. It was unknown if the patient had been COVID tested post vaccination. No follow-up attempts are possible; information about the lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037958
Sex: F
Age:
State: NC

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: it feels like when she has an allergic reaction; nasal congestion; chest tightness; diaphoresis; This is a spontaneous report from a contactable pharmacist. A 35-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3248), intramuscular on the left arm on 26Jan2021 10:15 at a single dose for COVID-19 immunization. Medical history included allergy to seafood. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0140), intramuscular on the left arm on 04Jan2021 08:00 for COVID-19 immunization. The most recent COVID-19 vaccine was administered at the hospital. Patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient complained of nasal congestion, chest tightness, and diaphoresis approximately 20 mins after the second COVID vaccine on 26Jan2021 10:30. She had an allergy to seafood and stated this was what it felt like when she had an allergic reaction. The patient received one dose of Benadryl 50 mg IV, famotidine 20 mg IV, Solumedrol 125 mg IV, Zofran 4 mg IV and normal saline 500ml bolus. Patient became nauseated after receiving Benadryl and improved after receiving medications. The events were reported non-serious and required emergency room/department or urgent care. Outcome of the events was recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The reported allergic reaction with symptoms of nasal congestion, chest tightness, and diaphoresis occurred approximately 20 mins after the second COVID vaccine is considered related to the COVID-19 vaccine, BNT162B2, based on the reasonable temporal association and the known safety profile of the suspect. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds:

Current Illness:

ID: 1037959
Sex: F
Age:
State: MI

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: COVID 19 Vaccine being administered incorrectly; This is a spontaneous report from a contactable pharmacist. This Pharmacist reported for a 53-year-old female patient that: Contact Details Patient Details Is the patient also the reporter: No Age: 53 Years Reporter Details Reporter type: Pharmacist Primary / Prescribing Healthcare Professional Info Event Details COVID 19 Vaccine Administered incorrectly Dates of adverse event: 19Jan2021- Seriousness criteria: Medically significant Products Suspect products: COVID 19 Vaccine Therapy dates: 19Jan2021- Is this a Pfizer product: Yes NDC number: 59267-1000-01 Lot Number: EL0142 Expiry date: 01Mar2021 What was the dose, dosage units, formulation, route of administration and frequency when the adverse event occurred: Administered in left arm Sodium Chloride Therapy dates: 19Jan2021 - NDC number: 63323018604 Lot Number: 6022719 Expiry date: Sep2022 History Concomitant Products Other Products: Unknown Other conditions Other Conditions: Unknown Investigations Investigations: Unknown Additional Context The report is cross referenced to report ID: # Report 2 of 2 Caller on the line calling about the COVID 19 Vaccine. She stated she tried to place a report a couple of weeks ago regarding the vaccine potentially being administered incorrectly. She was not able to reach anyone when she contacted us previously. She reached medical information, but she is unsure if she was able to make a report. She stated she spoke to someone in medical information and was sent information about her question. She was told she would receive a fax from us requesting additional information, but she has not received it yet. She provided these details, but unsure if a report was completed. Therefore, calling to follow-up to provide details. Caller does not have a reference number to provide. Height and Weight: Unknown Ethnicity: Unknown Caller further clarified COVID 19 Vaccine being administered incorrectly as they had an immunization nurse come to the (Institute name) to help with their vaccine clinic. For some reason unknown the nurse was giving people two shots at that vaccine administration. Nurse administered one shot that was of the diluted vaccine and one was of the diluent. Caller stated she does not know why the nurse did it this way. The patient has had no side effects from this occurrence that she is aware of. Seriousness Criteria: Medically Significant. She feels this way as the patient did not get the full dose and may not fully be protected against COVID 19. Caller stated she did not directly show the immunization nurse the process of how to administer. The caller was informed by the patient that she got two shots in one setting. Caller explained the 0.3ml of the diluted vaccine was administered with a 23G needle first and then the diluent was administered as a second shot. This patient got two separate shots. Exact diluent amount administered unknown. Stated it would make since for it to be 1.8ml because that is what is remaining in the vial. Nurse was not (Institute name) trained. Caller stated the nurse questioned if patients should get two shots as this is what she had been doing. Caller stated she informed the nurse yes, as she thought she was referencing the two different doses, first vaccine and then the second vaccine three weeks later. However, nurse was giving two different shots on the same day, the diluted vaccine and the diluent. Caller clarified the diluent to be Sodium Chloride 0.9%. Vaccine Supplemental Form Patient Last Name: (Name) Patient First Name: (Name) Address: # City: # State: # Zip code: # Phone: # Patient age at time of the vaccination: 53 Years Old Time the Vaccination was Given: Around 9:30AM Vaccine Lot Number: EL0142 Vaccine Lot Expire Date: 01Mar2021 Anatomical Location of Administration of Pfizer Vaccine considered as suspect: Left arm Vaccination Facility Type- Pharmacy/Drug Store Vaccination: Facility Address: Facility Name: See reporter details Address: See reporter details City: See reporter details State: See reporter details Zip Code: See reporter details Phone: See reporter details History of all previous immunization with the Pfizer Vaccine considered as suspect: None, first dose. Additional Vaccines Administered on Same Date of the Pfizer Suspect: None AE Details AE: COVID 19 Vaccine Administered incorrectly Time of onset: Around 9:30AM Did any of the AEs require a visit to: Emergency Room- No Physician Office- No Prior Vaccinations within 4 weeks: None Patient's Medical History: Unknown Relevant: Unknown; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of Product administration error due to temporal relationship. There is very limited information provided in this report. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: SODIUM CHLORIDE

Current Illness:

ID: 1037960
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Arm soreness; This is a spontaneous report from a non-contactable other healthcare professional (HCP; "Pharmacy tech"). A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (trade name unspecified, lot number: not provided), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm soreness on an unspecified date, after use of product. Outcome of the event was unknown. The reporter mentioned that arm soreness is a common occurrence when administering pneumococcal pneumonia vaccines. She did not mention which vaccine or any other details. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037961
Sex: M
Age:
State: CA

Vax Date: 02/01/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210204; Test Name: blood pressure; Result Unstructured Data: Test Result:high; Comments: 09:00 AM; Test Date: 20210204; Test Name: pulse rate; Result Unstructured Data: Test Result:low; Comments: 09:00 AM

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: BN5318, expiry date unknown) in the School or Student Health Clinic, via an unspecified route of administration on 01Feb2021 at 00:15 on the right arm at a single dose for COVID-19 immunization. Medical history included cardiac effusion and mild emphysema both from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ciclosporin (NEORAL), mycophenolate mofetil (CELLCEPT [MYCOPHENOLATE MOFETIL]) and losartan (manufacturer unknown). The patient previously took Cipro and tacrolimus and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced low pulse and high blood pressure on 04Feb2021 at 09:00. The patient did not receive any treatment for the event. The outcome of the events was unknown. The events were reported as non-serious. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: NEORAL; CELLCEPT [MYCOPHENOLATE MOFETIL]; LOSARTAN

Current Illness:

ID: 1037962
Sex: M
Age:
State: TX

Vax Date: 01/04/2021
Onset Date: 01/11/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: Liver function test; Result Unstructured Data: Test Result:Normal; Test Name: Renal function test; Result Unstructured Data: Test Result:Normal; Test Name: Thyroid function test; Result Unstructured Data: Test Result:Normal

Allergies:

Symptoms: This is a spontaneous report from a contactable physician. A 53-year-old male patient received his second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number pfel0410) on his left arm, intramuscular on 04Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included hypertension. The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 (first dose). It was reported that about 1 week after 2nd dose, the patient had diffuse edema of face, hands and legs. After edema resolved, skin on fingertips peeled off; all on 11Jan2021. Labs for kidney, liver and thyroid were checked and everything normal. No treatment was received for the events. The outcome of the events was recovered with sequel.

Other Meds:

Current Illness:

ID: 1037963
Sex: F
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a non-contactable consumer. A 61-year-old female patient (not pregnant, age at vaccination reported as 61-years-old) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration (left arm), on 02Feb2021, at single dose, for covid-19 immunization. Medical history included sulfa allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), for covid-19 immunization. The patient felt flu like symptoms the day after the second vaccination dose on 03Feb2021. Symptoms have resolved on the second day after vaccination. The patient recovered from the adverse event on 04Feb2021. No treatment was received for the adverse event. The patient did not have COVID prior vaccination and have not been COVID tested post vaccination. No follow-up attempts are possible; information about the lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037964
Sex: M
Age:
State: TX

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer reporting for himself. A 75-year-old male patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration on 20Jan2021 01:15 at SINGLE DOSE for covid-19 immunisation. Medical history included blood pressure (abnormal) from an unknown date. The patient was taking unspecified concomitant medications within 2 weeks of vaccination. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food or other products. The patient experienced dizziness, vertigo, falling on 20Jan2021 02:30. Treatment was not received. Outcome of the event was recovered with sequelae on an unspecified date. The reporter considered the events as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037965
Sex: F
Age:
State: PA

Vax Date: 01/25/2021
Onset Date: 02/02/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable other health professional (patient). A 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9261), via intramuscular route of administration on 25Jan2021 at 14:30 at a single dose on the left arm for COVID-19 immunization. The patient's medical history was reported as none. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), intramuscular on 04Jan2021 at 11:30 am (age: 54-years) on the left arm for Covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 02Feb2021, the patient experienced numbness in arms, hands, legs and feet. The patient did not receive any treatment for the reported event. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 1037966
Sex: M
Age:
State: NY

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left index finger feels like it was jammed; finger was in a lot of pain when moving left or right, even when washing his hands; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 03Feb2021 at 19:45 at a single dose on the arm left for COVID-19 immunization. Medical history included patient was diagnosed with COVID-19. Concomitant medications included naproxen sodium (ALEVE) and biotin. On 04Feb2021 at 03:00, the patient stated that his left index finger feels like it was jammed. The patient also stated that his finger was in a lot of pain when moving left or right, even when washing his hands. The patient did not receive any treatment for the reported events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. The events were assessed as non-serious. Information on the lot/batch number has been requested.

Other Meds: ALEVE; BIOTIN

Current Illness:

ID: 1037967
Sex: F
Age:
State: OH

Vax Date: 01/16/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210203; Test Name: Nasal Swab; Test Result: Positive ; Comments: Nasal Swab

Allergies:

Symptoms: positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable Other health care professional (patient). A 35-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Left arm on 16Jan2021 at 09:00 AM (at age of 35-year-old) as a single dose for COVID-19 immunisation, lot number: unknown. Medical history was reported as none. Patient had no allergies to medications, food, or other products. Concomitant medications within 2 weeks of vaccination included rhamnus cathartica, rhamnus purshiana, senna spp. (HERBAL) teas, cynara cardunculus, malus spp. vinegar extract, taraxacum officinale (APPLE CIDER), fluoxetine. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Patient caught covid on 30Jan2021 and she was unable to get second vaccine. Events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received. It was also reported that since the vaccination, the patient had been tested for COVID-19. She underwent laboratory tests and procedures which included sars-cov-2 test (Nasal Swab): positive on 03Feb2021. Patient was recovering from the event, at the time of the report. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. The case will be reassessed if additional information becomes available.

Other Meds: HERBAL; APPLE CIDER; FLUOXETINE

Current Illness:

ID: 1037968
Sex: M
Age:
State:

Vax Date: 01/20/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210201; Test Name: COVID-19 Test; Result Unstructured Data: Test Result:came down with covid

Allergies:

Symptoms: He came down with covid; This is a spontaneous report from a contactable Consumer (patient) A male patient received frist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 20Jan2021 at SINGLE DOSE for covid-19 immunization . The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated he came down with covid on 01Feb2021. Lab data included sars-cov-2 antibody test (01Feb2021): came down with covid (postitive) .The reporter added he received antibodies and was told not to take the second shot for 90 days. Outcome of the event was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1037970
Sex: F
Age:
State: PA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain and swelling in my lymph node in left armpit; Pain and swelling in my lymph node in left armpit; On 30Jan2021, the patient received the second dose BNT162B2 and first dose was received on 13Jan2021; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: EL8982), via an unspecified route of administration at the left arm on 30Jan2021 at a single dose for covid-19 immunization. The vaccine was administered in a hospital. The patient has no other medical history. There were no concomitant medications. The patient was not pregnant at the time of vaccination. Historical vaccine includes 1st dose of BNT162B2 for COVID-19 immunization, on 13Jan2021 12:00PM at the left arm, lot number: EL3246 at the age of 43 years. On 30Jan2021, the patient received the second dose BNT162B2 and first dose was received on 13Jan2021. On 01Feb2021 06:00 AM, the patient experienced pain and swelling in her lymph node in left armpit. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the adverse events. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The events pain and swelling in my lymph node in left armpit recovered on Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1037971
Sex: F
Age:
State: VA

Vax Date: 01/29/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lightheaded to the point of nearly passing out; nausea; general feeling of being unwell; lightheaded to the point of nearly passing out; cold sweat; loss of appetite; pain in upper shoulder/back area; pain in upper shoulder/back area; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL-9265), via an unspecified route of administration on 29Jan2021 12:30 in left arm, at single dose for covid-19 immunization. Medical history included chronic low BP, hypothyroidism, HRT, nasal allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included estradiol, levothyroxine sodium (SYNTHROID), multivitamin NOS (MULTIVITAMIN). The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and known allergies: Augmentin, being treated for nasal allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced nausea, general feeling of being unwell, lightheaded to the point of nearly passing out; cold sweat, loss of appetite, pain in upper shoulder/back area, on 01Feb2021 06:30. No treatment was received. The outcome of the events was recovering. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds: ESTRADIOL; SYNTHROID; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1037972
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itchy eyes; This is a spontaneous report from a non-contactable physician (patient). This physician reported similar events for two patients. This is the first of two reports. A female patient of an unspecified age (reported as age: 79, unit unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 26Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the Pfizer vaccine on 26Jan2021. Patient had itchy eyes that day and day after, then subsided. The next shot is scheduled for 26Feb2021, patient was struggling in making a decision on the second shot. Patient asked for any information on this side effect. The outcome of the event itchy eyes was recovered on an unknown date in 2021. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.; Sender's Comments: Linked Report(s) : same reporter/drug/AE, different patient.

Other Meds:

Current Illness:

ID: 1037973
Sex: F
Age:
State: VA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration (right arm) first dose on 29Jan2021 16:00 at single dose for covid-19 immunization. The patient's medical history included LBP (herniated disc and sciatica), GERD, IBS, PTSD, and allergies: Sulfa drugs. The patient was not pregnant at time of vaccination. The patient's concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), esomeprazole magnesium (NEXIUM), fluoxetine hydrochloride (PROZAC), cetirizine hydrochloride (ZYRTEC), and "Multi-vitamin". The patient previously took Ceclor and experienced allergies. On 29Jan2021 17:45, the patient noticed a slight headache, which I do not get often, and thought I might be slightly dehydrated, so the patient increased my water intake and drank 8 ounces of Gatorade. The headache got worse and when she was preparing to leave work, the patient was so much pain on the right, front side of my head lights, "noise", and walking hurt. The patient never had a migraine before, but I think this is what it was. The patient went home and took 2 Tylenol tablets, and went to bed. The patient woke up and in the morning with slight headache and took 2 more Tylenol tablets, and the headache subsided and did not return. The outcome of the events was recovered. The reporter assess the events as non-serious. Information on the lot/batch number has been requested.

Other Meds: ADDERALL; NEXIUM; PROZAC; ZYRTEC

Current Illness:

ID: 1037974
Sex: F
Age:
State: CA

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210202; Test Name: heart rate; Result Unstructured Data: Test Result:rapid; Comments: At night, my heart rate was rapid

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in the left arm on 02Feb2021 01:00 at single dose for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a workplace clinic. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included benazepril, atorvastatin calcium (LIPITOR), and ubidecarenone (COQ 10). On 02Feb2021 01:15, after 5 minutes getting the vaccine on her left arm, it started to get numb and her back and left leg. She had a headache and nausea. The nurse at the clinic took her to a room to rest and applied ice pack on her left arm. She stayed in the room for 2 hours. At night, her heart rate was rapid and she could not sleep. Next day, she had muscles sore and headache. Therapeutic measure was taken as a result of numbness in the left arm,. No treatment was received for the other events. Clinical outcome of the events was recovered with sequelae. Information on the lot/batch number has been requested.

Other Meds: BENAZEPRIL; LIPITOR; COQ 10

Current Illness:

ID: 1037976
Sex: F
Age:
State: IN

Vax Date: 01/05/2021
Onset Date: 01/08/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: Ultrasound; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL0142, expiry date unknown), intramuscular in the left arm, on 05Jan2021 17:30, at single dose, for COVID-19 immunization, at the hospital. Medical history included asthma and high cholesterol. The patient has no allergy to medications, foot or other products. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included atorvastatin (LIPITOR) and ethinylestradiol, norgestrel (CRYSELLE). The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient experienced upper left swollen lymph nodes (4) on 08Jan2021 13:30. The patient postponed 2nd shot until this is resolved. Ultrasound was done and was told biopsy was needed next. Therapeutic measures were taken as a result of upper left swollen lymph nodes (4) included ultrasound (as reported) on an unspecified date with unknown results. The event resulted to "doctor or other healthcare professional office/clinic visit". The outcome of the event was not resolved.

Other Meds: LIPITOR [ATORVASTATIN]; CRYSELLE

Current Illness:

ID: 1037978
Sex: F
Age:
State: NY

Vax Date: 01/01/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210130; Test Name: covid_test; Test Result: Positive

Allergies:

Symptoms: Tested positive for COVID-19 approximately 2 weeks after receiving her second dose of vaccine; Tested positive for COVID-19 approximately 2 weeks after receiving her second dose of vaccine; This is a spontaneous report from a contactable consumer. A 93-year-old female patient not pregnant received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unknown date in Jan2021 (at age of 93-year-old) as a single dose for COVID-19 immunisation, lot number: unknown. Medical history and concomitant medications were not provided. It was unknown if patient received other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Patient was tested positive for COVID-19 approximately two weeks after receiving her second dose of vaccine, onset date 30Jan2021. Event resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if treatments were administered. The patient underwent laboratory tests and procedures which included sars-cov-2 test: positive on 30Jan2021. Patient had not recovered at the time of the report. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037979
Sex: F
Age:
State: MA

Vax Date: 01/19/2021
Onset Date: 01/22/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 2021; Test Name: mammogram and ultrasound of left breast; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: mammogram and ultrasound of left breast; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: my left breast started draining clear/white fluid; there is associated pain radiating down towards the nipple from the top of the breast and along the left side of the breast; This is a spontaneous report from a contactable nurse who reported for herself This 44-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot# EL3247 in the left arm on 19Jan2021 at SINGLE DOSE for covid-19 immunization . Facility where the most recent COVID-19 vaccine was administered:Workplace clinic.Age at vaccination 44 years.The patient received the first dose of the same vaccine from Lot # EL1284 on 29Dec2020 via intramuscular , on the Left arm .Tthe patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypothyroidism , gestational diabetes ,Allergies: Bees (anaphylaxis) , Allergy: shrimp (gastrointestinal) .Concomitant medication included levothyroxine , alprazolam , procaterol hydrochloride (PRO-AIR), chlorphenamine maleate (CHLOR) and vitamin d . The patient reported as follows :"On 22Jan2021 18:00 my left breast started draining clear/white fluid. Additionally there was associated pain radiating down towards the nipple from the top of the breast and along the left side of the breast that has lasted two weeks and continues".Lab data included mammogram (2021): unknown results .ultrasound left breast (2021): unknown results.The adverse event result in Doctor or other healthcare professional office/clinic visit.Events were treated (I have had to have a mammogram and ultrasound of left breast and am awaiting an MRI.Levaquin ).Events reported as non serious.Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19.Outcome of the events was not recovered.

Other Meds: LEVOTHYROXINE; ALPRAZOLAM; PRO-AIR; CHLOR; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1037980
Sex: M
Age:
State:

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: General body fatigue; mental fatigue (moderate); This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old male consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Feb2021 at single dose for COVID-19 immunisation at the age of 32-year-old. Medical history was none. Concomitant medications were unknown. On 05Feb2021 at 05:30, the patient experienced general body fatigue and mental fatigue (moderate). The outcome of the events was unknown. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037981
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: covid virus; Test Result: Negative

Allergies:

Symptoms: she was diagnosed with pneumonia; Valley fever; This is a spontaneous report from a Pfizer Sponsored Program, Pfizer First Connect. A contactable female consumer of unspecified age (patient) received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date, for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, 2 days after vaccination, the patient was diagnosed with pneumonia and Valley fever. The patient was tested negative for the COVID virus on an unknown date. Her second BNT162B2 dose was scheduled for 15Feb2021. Events outcome was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037982
Sex: F
Age:
State: PA

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable other healthcare professional (patient). A 24-year-old female patient at same age receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9263), intramuscular in left arm on 03Feb2021 12:00 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced muscular soreness for 24 hours (04Feb2021 12:00), fatigue for 6 hours (03Feb2021 18:00), nausea 12 hours (04Feb2021 00:00) after injection, lasting for 6 hours. The outcomes of events were unknown. The patient was not pregnant at the time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1037983
Sex: F
Age:
State: MA

Vax Date: 01/26/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210204; Test Name: COVID-19 (nasal swab); Test Result: Positive

Allergies:

Symptoms: Tested positive for COVID 19; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 26Jan2021,14:45 (lot number: EL3247), at the age of 51-years via an unspecified route of administration in the left arm at single dose for COVID-19 immunization in the workplace clinic. The patient's medical history was not reported. The patient did not receive other vaccines within four weeks. The patient had no concomitant medications. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with Covid-19 prior to vaccination and was tested after the vaccination for COVID-19. The patient experienced tested positive for COVID-19 on 04Feb2021. The adverse events required doctor or other healthcare professional office/clinic visit. The patient did not received treatment. The patient underwent COVID-19 (Nasal Swab) test on 04Feb2021 which was positive. The consumer assessed the events as non-serious. The outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1037984
Sex: F
Age:
State: PA

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A lot of pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3247) via an unspecified route of administration on the left arm on 04Feb2021 09:15 at a single dose for COVID-19 immunization. Medical history included high blood pressure and coronary artery (disease). Concomitant medication included valsartan, rosuvastatin calcium (ROSUVASTIN) and acetylsalicylic acid (BABY ASPIRIN). On 04Feb2021 14:30 the patient experienced a lot of pain at the injection site. No treatment was received for the event. Event was reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The facility where the vaccine was administered was in a workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Outcome of the event was recovering.

Other Meds: VALSARTAN; ROSUVASTIN; BABY ASPIRIN

Current Illness:

ID: 1037985
Sex: M
Age:
State: MI

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received his second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3248; expiration date: unknown), via an unspecified route of administration right arm on 04Feb2021 07:45 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient received his first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3248; expiration date: unknown) at the vaccination age of 52-year-old via an unspecified route of administration left arm on 14Jan2021 08:45 AM at a single dose for covid-19 immunization. On 04Feb2021 04:45 PM, the patient reported that he believed he experienced an ocular migraine in his left eye approximately 9 hours after getting the second shot. He took 2 acetaminophen 500 mg tablets and the symptoms cleared up in 20-30 minutes. He has never experienced this sort of sensation before so he figures it could possibly be related. He woke up with a mild headache at the start of this second day (05Feb2021), as well. The events were non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event ophthalmic migraine was recovered on 04Feb2021 while headache was recovered on Feb2021.

Other Meds:

Current Illness:

ID: 1037986
Sex: F
Age:
State:

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site tenderness; This is a spontaneous report from a non-contactable consumer (patient). A 25-year-old female consumer received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Feb2021 at 07:45 at single dose in left arm for COVID-19 immunisation at the age of 25-year-old. Lot number was EL9264. Pregnant was not pregnant at the time of vaccination. Medical history included asthma, allergies, anxiety, frequent bronchitis. Concomitant medications included mefenamic acid (ADVIL), sertraline hydrochloride (ZOLOFT), fluticasone propionate (ARMONAIR), fexofenadine hydrochloride (ALLEGRA), ipratropium bromide (IPRATROPIUM BROM). The patient experienced Injection site tenderness on 04Feb2021 at 13:00; the patient was not treated for the event. The patient recovered from the event. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds: ADVIL; ZOLOFT; ARMONAIR; ALLEGRA; IPRATROPIUM BROM

Current Illness:

ID: 1037987
Sex: M
Age:
State: CA

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: covid test; Test Result: Negative

Allergies:

Symptoms: Muscle and joint pain; Muscle and joint pain; fever; severe chills; nausea; vomiting; fatigue; severe headache; injection site pain; severe feeling of sickness; This is a spontaneous report from a contactable nurse reported for himself that: A 69-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) form LOT# EJ1685 on left arm on 22Dec2020 10:00 at SINGLE DOSE for covid-19 immunization.Age at vaccination: 69 Years Medical history included flu (almost 43 years ago). The patient's concomitant medications were not reported. Facility where the most recent COVID-19 vaccine was administered: Hospital. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced muscle and joint pain, fever, severe chills, severe shivering, nausea, vomiting, fatigue, severe headache, injection site pain and a severe feeling of sickness. This severe feeling of sickness was the worst feeling of sickness that I have had in my life, only equal to the most sick I have felt in my life, which was the last time I had the flu, which was almost 43 years ago. This began about 9 hours after I got my second vaccine shot. This lasted about 36 hours, the worst of it about 4 hours. Lab data sars-cov-2 test (unknown date): negative. No treatment received. Events were reported as non-serious. Outcome of the events was recovered.

Other Meds:

Current Illness:

ID: 1037988
Sex: F
Age:
State: OK

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lymph node swelling on collar bone area; Excessive belching without other potential trigger; This is a spontaneous report from a contactable pharmacist. A 35-year-old female pharmacist reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN5318), intramuscular into the left arm on 02Feb2021 at 04:30 PM at single dose for COVID-19 immunization. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Concomitanr drugs were unknown. The patient experienced excessive belching without other potential trigger days 1 and 2 after vaccination and lymph node swelling on collar bone area 3 days after vaccination. No treatment was received. the outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1037989
Sex: F
Age:
State: IL

Vax Date: 12/19/2020
Onset Date: 12/26/2020
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Paresthesias in feet and hands, strongest in the left hand; This is a spontaneous report from a contactable physician (patient). A non-pregnant 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm, on 19Dec2020 at 09:30 AM, at a single dose, for COVID-19 immunization. The patient's medical history included tinnitus, intermittent vertigo, and non-anaphylactic allergy to egg. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 26Dec2020, the patient experienced paresthesias in feet and hands, strongest in the left hand. The event was considered non-serious. No treatment was received for the adverse event. The patient was administered with the second dose of BNT162B2 (Lot Number: EJ1283) on 09Jan2021 at 09:30 AM in left arm. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the event.

Other Meds:

Current Illness:

ID: 1037990
Sex: M
Age:
State: FL

Vax Date: 02/02/2021
Onset Date: 02/04/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210205; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown results; Comments: Covid test result Pending

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 02Feb2021 08:45 at single dose for COVID-19 immunization. Medical history included stage 4 prostate cancer. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has been tested for COVID-19. Concomitant medications were not reported. The patient previously took celecoxib (CELEBREX) and experienced allergies. On 04Feb2021, the patient experienced extreme soreness on side where injection was given, also had malaise and tiredness. The patient underwent lab tests and procedures which included SARS-COV-2 test: unknown results (COVID test result Pending) on 05Feb2021. No treatment was received for the adverse events. Clinical outcome of the events was recovered/resolved with sequel (reported as recovered with lasting effects). Information on the lot/batch number has been requ

Other Meds:

Current Illness:

ID: 1037991
Sex: F
Age:
State: NJ

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient (not pregnant) received the first dose of bnt162b2 (BNT162B2 also reported as product COVID 19 brand Pfizer, lot/batch number and expiry date were not reported), via an unspecified route of administration in left arm on 05Feb2021 08:15 at SINGLE DOSE for Covid-19 immunisation. Medical history included colorectal cancer and thyroid cancer. She had allergies to sulfur. She did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included levothyroxine sodium (LEVOXYL). The patient experienced her lips felt swollen and numb for about one hour after the dose was administered (non-serious) on 05Feb2021. No treatment was given. The outcome of events was recovered on unspecified date in Feb2021. Information on the lot/batch number has been requested.

Other Meds: LEVOXYL

Current Illness:

ID: 1037992
Sex: F
Age:
State: SC

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient (not pregnant) received first dose bnt162b2 (BNT162B2 also reported as product COVID 19 brand Pfizer, lot/batch number expiry date not reported), via an unspecified route of administration in left arm on 05Feb2021 00:45 at SINGLE DOSE for Covid-19 immunisation. Medical history included blood pressure abnormal and chronic kidney disease. She did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included citalopram, diltiazem, amlodipine, calcitriol and iron. The patient experienced cold sweat, slight fever and chills (all non-serious) on 06Feb2021 03:00, no treatment. The outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds: CITALOPRAM; DILTIAZEM; AMLODIPINE; CALCITRIOL; IRON

Current Illness:

ID: 1037993
Sex: F
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe pain and swelling at injection site; Severe pain and swelling at injection site; This is a spontaneous report from a non-contactable other healthcare professional (patient). A 51-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9810), via an unspecified route of administration (right arm) on 05Feb2021 12:00 (at the age of 51years) at single dose for Covid-19 immunization. The patient received the first dose of BNT162B2 (lot number: EL3247) on 15Jan2021 (10:00AM) (at the age of 51years) at right arm for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in Feb2021, the patient experienced severe pain and swelling at injection site. There was no treatment received for the adverse events. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1037994
Sex: M
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: they gave him 6 times the amount of the regular dosage; pharmacist made a mistake.; This is a spontaneous report from a contactable consume reported on behalf of (her fiancee). A 25-years-old male patient (medical student) received the first dose of bnt162b2 (BNT162B2, Lot Number Unknown) via an unspecified route of administration on 05Feb2021 as a Single Dose for covid-19 immunisation. The patient had no known medical history. There were no concomitant medications. Reporter does not have his vaccine card with her therefore could not provide the Lot Number or Expiration Date. On 05Feb2021, the patient experienced they gave him 6 times the amount of the regular dosage. The patient received a call from (Specialty Pharmacy name) informing him they gave him 6 times the normal dose. They said '1.8 and 0.3 was what he was supposed to get'. The patient was not given any details about how this occurred they just said the pharmacist made a mistake. The patient feels fine but customer service at (Specialty Pharmacy name) did not provide the patient with a lot of information. Consumer inquired Do they basically just monitor him? The reporter was unsure if (Specialty Pharmacy name) reported this incident to Pfizer. The clinical outcome of the event accidental overdose and product administration error was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1037995
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Coughed and wheezed for 5 years after Prevnar shot; Coughed and wheezed for 5 years after Prevnar shot; This is a spontaneous report from a contactable consumer. A 70-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Solution for injection in pre-filled syringe), via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient coughed and wheezed for 5 years after PREVNAR shot. Said stopped wheezing after heavy antibiotics, Ciprofloxacin and Cefazolin duplex. It was reported that event took place after use of product. The outcome of wheezing was recovered while another event was unknown. Information regarding lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm